Fact CheckerSign in

NCT07320300Not yet recruiting

Post Stroke Cognitive Impairment

Evaluation of Post-Stroke Cognitive Impairment in Patients Attending the Neuropsychiatry Department- Assiut University

Source: ClinicalTrials.gov · Last updated 6 Jan 2026

Brief summary (registry, in English)

clinical evaluation of the prevalence and severity of cognitive impairment among patients after ischemic and haemorrhagic stroke admitted to the Neuropsychiatry department

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
400 (estimated)
First submitted
22 Nov 2025
Start date
1 Jan 2026
Primary completion date
30 Nov 2027
Lead sponsor
Assiut University
Diseases
Stroke
NCT number
NCT07320300

What you commit to

  • Study type: Observational
  • Planned participants: 400
  • From 1 Jan 2026 to the primary completion date, 30 Nov 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Age above 60 years, refusal to participate in the study, pre-existing dementia or significant psychiatric illness, severe aphasia or communication deficits precluding cognitive testing or severe comorbid condition limiting follow-ups, systemic diseases that are known to affect the central nervous system, such as (thyroid dysfunction, chronic infections, or system failure like liver or renal failure), significant sensory impairment (deafness and blindness), history of malignancy and those who have had neurosurgical procedures or severe head trauma at any time before a stroke.

Who the study is looking for

  • Patients of both sexes, aged 18- 60 years, with a history of first stroke within 3 months of admission, all types of stroke confirmed by imaging (ischemia, parenchymal haemorrhage, subarachnoid haemorrhage, venous stroke)

Age in the registry: 18 years to 60 years · Sex: All

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.